Vaxxas
Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines.
Company Operating Status
Active
Country
Crunchbase URL
Email Address
Founded Date
January 1, 2011
Founder
Latest Funding Round Date
August 25, 2025
Latest Funding Round Amount (USD)
60,000,000
Latest Funding Type
LinkedIn URL
Location
Patents Assigned (Count)
1
Total Funding Amount (USD)
82,820,000
Official Website
Find more companies like Vaxxas
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.